

I can sit through a biotech presentation and come away convinced that the company has discovered the answer to half the problems in modern medicine. The...
You can purchase shares of Xenon Pharmaceuticals (NASDAQ:XENE) through any online brokerage.
Other companies in Xenon Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Xenon Pharmaceuticals has a consensus price target of $61.89.
The stock price for Xenon Pharmaceuticals (NASDAQ: XENE) is $35.775 last updated October 28, 2026 at 10:23 AM EDT.
There are no upcoming dividends for Xenon Pharmaceuticals.
Xenon Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Xenon Pharmaceuticals.
Xenon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet...